Artia Global Partners LP Ultragenyx Pharmaceutical Inc. Transaction History
Artia Global Partners LP
- $416 Billion
- Q2 2025
A detailed history of Artia Global Partners LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 41,830 shares of RARE stock, worth $1.31 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
41,830Holding current value
$1.31 Million% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
364Shares Held
89.1MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$319 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$175 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$123 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$90.1 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$86.5 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.19B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...